Thom Browne

468 total citations
20 papers, 316 citations indexed

About

Thom Browne is a scholar working on Clinical Psychology, Toxicology and Epidemiology. According to data from OpenAlex, Thom Browne has authored 20 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Clinical Psychology, 7 papers in Toxicology and 4 papers in Epidemiology. Recurrent topics in Thom Browne's work include Forensic Toxicology and Drug Analysis (7 papers), Substance Abuse Treatment and Outcomes (4 papers) and Migration, Health and Trauma (3 papers). Thom Browne is often cited by papers focused on Forensic Toxicology and Drug Analysis (7 papers), Substance Abuse Treatment and Outcomes (4 papers) and Migration, Health and Trauma (3 papers). Thom Browne collaborates with scholars based in United States, Sri Lanka and Mexico. Thom Browne's co-authors include David M. Martin, Barry K. Logan, Taís Regina Fiorentin, Alex J. Krotulski, Knowlton Johnson, Linda Young, Silvia L. Cruz, Stephen R. Shamblen, Anne N. Nafziger and Melissa H. Abadi and has published in prestigious journals such as Addiction, Drug and Alcohol Dependence and Forensic Science International.

In The Last Decade

Thom Browne

20 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thom Browne United States 8 98 85 62 49 44 20 316
Kraig E. Strayer United States 9 171 1.7× 176 2.1× 68 1.1× 59 1.2× 22 0.5× 11 376
Paolo Berretta Italy 10 162 1.7× 75 0.9× 29 0.5× 27 0.6× 18 0.4× 20 331
Joachim Frost Norway 12 227 2.3× 147 1.7× 55 0.9× 49 1.0× 15 0.3× 32 472
Aaron M. Shapiro Canada 11 149 1.5× 170 2.0× 99 1.6× 17 0.3× 17 0.4× 18 371
T. Robert United States 11 198 2.0× 106 1.2× 24 0.4× 30 0.6× 14 0.3× 17 342
Julie Kloss United States 11 222 2.3× 124 1.5× 15 0.2× 18 0.4× 30 0.7× 15 410
Michael Scott-Ham United Kingdom 7 209 2.1× 64 0.8× 51 0.8× 14 0.3× 14 0.3× 8 333
Matthew Di Rago Australia 11 301 3.1× 77 0.9× 42 0.7× 72 1.5× 15 0.3× 20 413
Matthew Juhascik United States 12 315 3.2× 302 3.6× 125 2.0× 77 1.6× 32 0.7× 18 556
Wakako Hikiji Japan 12 53 0.5× 84 1.0× 14 0.2× 28 0.6× 13 0.3× 29 378

Countries citing papers authored by Thom Browne

Since Specialization
Citations

This map shows the geographic impact of Thom Browne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thom Browne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thom Browne more than expected).

Fields of papers citing papers by Thom Browne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thom Browne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thom Browne. The network helps show where Thom Browne may publish in the future.

Co-authorship network of co-authors of Thom Browne

This figure shows the co-authorship network connecting the top 25 collaborators of Thom Browne. A scholar is included among the top collaborators of Thom Browne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thom Browne. Thom Browne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Browne, Thom, et al.. (2024). Effects of fentanyl and the adulterant levamisole on the rewarding and locomotor effects of methamphetamine in rats. Drug and Alcohol Dependence. 256. 111098–111098. 2 indexed citations
2.
Strathmann, Frederick G., et al.. (2023). Analysis of umbilical cord tissue as an indicator of in utero exposure to toxic adulterating substances. Frontiers in Pediatrics. 11. 1127020–1127020. 4 indexed citations
3.
Browne, Thom, et al.. (2023). Xylazine potentiates the lethal but not the rewarding effects of fentanyl in mice. Drug and Alcohol Dependence. 253. 110993–110993. 14 indexed citations
4.
Browne, Thom, et al.. (2022). Co‐administration of morphine and levamisole increases death risk, produces neutropenia and modifies antinociception in mice. Addiction Biology. 27(3). e13166–e13166. 4 indexed citations
5.
Strathmann, Frederick G., et al.. (2021). Qualitative LC–Q-TOF Analysis of Umbilical Cord Tissue via Data-Dependent Acquisition as an Indicator of In Utero Exposure to Toxic Adulterating Substances. Journal of Analytical Toxicology. 46(6). 619–624. 4 indexed citations
6.
Browne, Thom, Mark S. Gold, & David M. Martin. (2021). The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19. 10(2). 138–154. 6 indexed citations
7.
White, C Michael, Thom Browne, & Anne N. Nafziger. (2021). Inherent Dangers of Using Non–US Food and Drug Administration–Approved Substances of Abuse. The Journal of Clinical Pharmacology. 61(S2). S129–S141. 9 indexed citations
8.
Fiorentin, Taís Regina, et al.. (2020). Assessment of a portable quadrupole-based gas chromatography mass spectrometry for seized drug analysis. Forensic Science International. 313. 110342–110342. 47 indexed citations
9.
Jones, Hendrée E., et al.. (2019). The CHILD Intervention for Living Drug-Free Comprehensive Assessment of Risk, Resilience, and Experience (CHILD CARRE) Measure: Initial Findings. Journal of Child & Adolescent Substance Abuse. 28(6). 411–425. 3 indexed citations
10.
Browne, Thom, et al.. (2019). The Emerging Role of Toxic Adulterants in Street Drugs in the US Illicit Opioid Crisis. Public Health Reports. 135(1). 6–10. 74 indexed citations
11.
Fiorentin, Taís Regina, et al.. (2018). Detection of Cutting Agents in Drug‐Positive Seized Exhibits within the United States. Journal of Forensic Sciences. 64(3). 888–896. 72 indexed citations
12.
Browne, Thom, et al.. (2017). Implementation and Evaluation of an Intervention for Children in Afghanistan at Risk for Substance Use or Actively Using Psychoactive Substances. International Journal of Pediatrics. 2017. 1–10. 4 indexed citations
13.
Jones, Hendrée E., et al.. (2015). Little Fly Wing: a new drug of concern in Argentina. Addiction. 110(9). 1534–1535. 1 indexed citations
14.
Abadi, Melissa H., et al.. (2014). Gender differences in Afghan drug-abuse treatment: an assessment of treatment entry characteristics, dropout, and outcomes. Ethnicity and Health. 20(5). 453–473. 3 indexed citations
15.
Johnson, Knowlton, et al.. (2013). Drug use and treatment success among gang and non-gang members in El Salvador: a prospective cohort study. Substance Abuse Treatment Prevention and Policy. 8(1). 20–20. 7 indexed citations
17.
Abadi, Melissa H., et al.. (2012). Examining human rights and mental health among women in drug abuse treatment centers in Afghanistan. International Journal of Women s Health. 4. 155–155. 7 indexed citations
18.
Johnson, Knowlton, et al.. (2012). Evaluation of the Therapeutic Community Treatment Model in Thailand: Policy Implications for Compulsory and Prison-Based Treatment. Substance Use & Misuse. 47(8-9). 889–909. 13 indexed citations
19.
Johnson, Knowlton, et al.. (2008). Therapeutic community drug treatment success in Peru: a follow-up outcome study. Substance Abuse Treatment Prevention and Policy. 3(1). 26–26. 13 indexed citations
20.
Browne, Thom. (1974). The Treatment of Hydrofluoric Acid Burns. Occupational Medicine. 24(3). 80–89. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026